Lipella Pharmaceuticals I...

NASDAQ: LIPO · Real-Time Price · USD
0.64
0.00 (0.05%)
At close: Aug 15, 2025, 2:41 PM
0.64
0.00%
After-hours: Aug 15, 2025, 02:41 PM EDT

Lipella Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-5.02M -4.62M -2.6M -1.87M
Depreciation & Amortization
2.89K 1.69K n/a n/a
Stock-Based Compensation
749.4K 1.36M 747.4K 728.8K
Other Working Capital
-136.94K 237.23K -327.93K 175.25K
Other Non-Cash Items
200K 121.2K 9.61K -50.21K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
113.23K -9.11K 9.52K 197.61K
Operating Cash Flow
-3.95M -3.15M -1.83M -989.27K
Capital Expenditures
n/a -14.43K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a 300.55M -300.55K
Sales Maturities Of Investments
n/a n/a 300.55K n/a
Other Investing Acitivies
n/a n/a -300.55M -300.55K
Investing Cash Flow
n/a -14.43K 300.55K -300.55K
Debt Repayment
n/a -275K 275K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 1.61M n/a n/a
Financial Cash Flow
2.84M 1.34M 5.24M 2.1M
Net Cash Flow
-1.11M -1.83M 3.71M 807.09K
Free Cash Flow
-3.95M -3.16M -1.83M -989.27K